Literature DB >> 9602336

Fatal pleomorphic xanthoastrocytoma with meningeal gliomatosis.

N Leonard1, D A Alcutt, M A Farrell.   

Abstract

AIMS: To report the previously undescribed phenomenon of extensive meningeal gliomatosis in a pleomorphic xanthoastrocytoma (PXA) and to examine possible prognostic features. CASE DETAILS: An 11-year-old girl underwent excision of a left temporoparietal pleomorphic xanthoastrocytoma and 8 months later underwent re-excision of a local tumour recurrence. Although mitoses were not present in any of the resection specimens, the development of necrosis and increased immunoreactivity for proliferating cell nuclear antigen (PCNA) indicated anaplastic transformation in the recurrent tumour. Three months later extensive meningeal gliomatosis with minimal local recurrence resulted in death.
CONCLUSIONS: Subarachnoid dissemination of a locally recurrent PXA in the absence of mitotic activity is an extremely unusual occurrence. PCNA expression in the initial excision specimens did not predict subsequent anaplastic transformation.

Entities:  

Mesh:

Year:  1998        PMID: 9602336     DOI: 10.1046/j.1365-2559.1998.00407.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Pleomorphic xanthoastrocytoma with malignant transformation and multiple recurrences in an Iranian girl.

Authors:  Fariba Binesh; Ali Akhavan; Hossein Navabii
Journal:  BMJ Case Rep       Date:  2012-03-20

2.  Metastatic Low-Grade Gliomas in Children: 20 Years' Experience at St. Jude Children's Research Hospital.

Authors:  Omar Chamdine; Alberto Broniscer; Shengjie Wu; Amar Gajjar; Ibrahim Qaddoumi
Journal:  Pediatr Blood Cancer       Date:  2015-08-27       Impact factor: 3.167

3.  Non-anaplastic pleomorphic xanthoastrocytoma with neuroradiological evidences of leptomeningeal dissemination.

Authors:  Eva Passone; Stefano Pizzolitto; Serena D'Agostini; Miran Skrap; Maria Paola Gardiman; Agostino Nocerino; Giovanni Scarzello; Giorgio Perilongo
Journal:  Childs Nerv Syst       Date:  2005-12-21       Impact factor: 1.475

Review 4.  Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon.

Authors:  Giorgio Perilongo; Maria Luisa Garrè; Felice Giangaspero
Journal:  Childs Nerv Syst       Date:  2003-04-05       Impact factor: 1.475

5.  Pleomorphic xanthoastrocytomas: immunohistochemistry, grading and clinico-pathologic correlations. An analysis of 34 cases from a single Institute.

Authors:  A Korshunov; A Golanov
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

6.  Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis.

Authors:  Stephanie M Perkins; Nandita Mitra; Wan Fei; Eric T Shinohara
Journal:  J Neurooncol       Date:  2012-07-28       Impact factor: 4.130

7.  Cerebral anaplastic pleomorphic xanthoastrocytoma with meningeal dissemination at first presentation.

Authors:  Alphonse Lubansu; Sandrine Rorive; Philippe David; Eric Sariban; Roland Seligmann; Jacques Brotchi; Benoit Pirotte
Journal:  Childs Nerv Syst       Date:  2003-12-11       Impact factor: 1.475

Review 8.  Aggressive behavior and anaplasia in pleomorphic xanthoastrocytoma: a plea for a revision of the current WHO classification.

Authors:  Nesibe Kahramancetin; Tarik Tihan
Journal:  CNS Oncol       Date:  2013-11

Review 9.  Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis--a pediatric case report and review of the literature.

Authors:  Toshiyuki Okazaki; Teruyoshi Kageji; Kazuhito Matsuzaki; Hidehisa Horiguchi; Takanori Hirose; Hiroyoshi Watanabe; Toshihiro Ohnishi; Shinji Nagahiro
Journal:  J Neurooncol       Date:  2009-03-27       Impact factor: 4.130

10.  Pleomorphic xanthoastrocytoma: a developmental glioneuronal tumor with prominent glioproliferative changes.

Authors:  So-Hyang Im; Chun Kee Chung; Seung-Ki Kim; Byung-Kyu Cho; Min-Kyung Kim; Je G Chi
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.